Default: Drug Discovery Today

ISSN: 1359-6446

Journal Home

Journal Guideline

Drug Discovery Today Q1 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Discovery Today is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 175. It has a price of 2395 €. It has an SJR impact factor of 1,778 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,778.

Drug Discovery Today focuses its scope in these topics and keywords: drug, library, cancer, discovery, clinical, development, drugs, data, crowd, class, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Drug Discovery Today

1,778

SJR Impact factor

175

H Index

258

Total Docs (Last Year)

667

Total Docs (3 years)

19752

Total Refs

5142

Total Cites (3 years)

630

Citable Docs (3 years)

7,17

Cites/Doc (2 years)

76,56

Ref/Doc

Aims and Scope


drug, library, cancer, discovery, clinical, development, drugs, data, crowd, class, chitosanbased, gastrointestinal, diabetes, diabetesrenaissance, discoverypcsk, discoverywhat, donors, dopamine, challengeschemogenomics, challenges, analogue, antibodies, approach, approaches, approachescellbased, binding, biology, biomarkers, biomedicinetherapeutic, brain, brainhow, caflux, campaignsan,



Best articles by citations

New antibody therapies for HIV

View more

Chemokines and their receptors

View more

Sweet signal transduction

View more

Project acceleration - the case for quantum change

View more

Dizzying but scary: looking towards R&D in 2005

View more

Targeted molecular diversity in drug discovery: Integration of structure-based design and combinatorial chemistry

View more

Challengeability of biotechnology patents in the light of Biogen v. Medeva

View more

Could insulin protect against atherosclerosis?

View more

Passion versus fear as the emotion driving scientists

View more

Using the power of developmental biology for drug discovery

View more

Project Management for Successful Product Innovation

View more

Preparation of secondary amines

View more
SHOW MORE ARTICLES

Chiral Europe '95

View more

People

View more

Targeted taxane therapy for cancer

View more

People

View more

Working with worms

View more

Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery

View more

Antimalarial drug discovery: development of inhibitors of dihydrofolate reductase active in drug resistance

View more

Beating superbugs with the Gulliver effect

View more

Monitor and Molecules

View more

Erratum

View more

Monitor: molecules and profiles

View more

Monitor: molecules and profiles

View more

Comments

No comments ... Be the first to comment!

FAQS